Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
about
Interleukin-32 promotes osteoclast differentiation but not osteoclast activationEmerging Functions of RANKL in Lymphoid TissuesTACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulationA novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesisFLRG, a new ADAM12-associated protein, modulates osteoclast differentiationReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6RANK is essential for osteoclast and lymph node developmentCCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to boneJun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKLGene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formationExposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiationA model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKLBone loss. Factors that regulate osteoclast differentiation: an update.The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.Anti-cytokine therapy in chronic destructive arthritisAnti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.Ubc13: the Lys63 ubiquitin chain building machineRoles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular DiseaseRANK-RANKL signalling in cancerThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisProstate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsUse of Animal Models in Understanding Cancer-induced Bone PainBone health and associated metabolic complications in neuromuscular diseasesMutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysisDisabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivoThe regulation of cathepsin K gene expressionPhysical and functional association of c-Src and adhesion and degranulation promoting adaptor protein (ADAP) in osteoclastogenesis in vitroKey roles of the OPG-RANK-RANKL system in bone oncologyNF-kappaB-related genetic diseasesRANKL/RANK-beyond bonesRole of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and graspingMechanisms of action of therapeutic antibodies for cancerTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingAn inducible, ligand-independent receptor activator of NF-κB gene to control osteoclast differentiation from monocytic precursorsArctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathwaysTargeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasisWnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodiesOsteoclast differentiation and activationRANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro
P2860
Q21092154-00780859-1EB8-4A4B-848D-92C75DFBF29FQ21131222-CCCD95FA-C3FA-4FBF-9B4F-B46B17A9165CQ22254448-BAFCBE93-AB1E-48C5-B593-C183A0CAFACEQ24292059-273CF3D7-8BE5-4DB8-9211-F9F3E15802F6Q24311417-6BD4B63C-2227-4E70-B0B7-DAF6F31347A7Q24318438-9A707F27-6487-4C56-91EF-6DA4C585B6ABQ24537518-269CD1DD-7C58-4D38-9E3B-B1CDF7F7018FQ24598872-201E2CE2-B286-46CC-A755-33687F243FCDQ24609211-B88EB2B7-D654-40E2-A690-454472E75244Q24673624-DA9F5375-5329-4D12-80B9-A509AE35D5E5Q24681552-340D32C9-F100-4B3E-A4F3-7566717F48D7Q24796088-9EC6F688-22C8-4870-AF23-444FC0FBAB1FQ24799036-51414188-629A-4C7C-BDAB-4CD4982B9556Q24805142-66900F39-C174-4CD0-ACFA-B5209E0DC6BEQ24805207-B4B55A2A-363B-428E-8E57-FF4860DB09BAQ24805245-27885587-EEBB-48E7-9B89-6A504D899319Q24806847-E14B8123-3B81-4515-9194-AB8D70A9EC0EQ26739716-C0A56503-1A27-46FE-820B-C0B87679831BQ26747224-85529753-73C9-43FE-B988-6880F7BEC753Q26747442-CA3D3BB1-00DF-466B-9B0C-76497D3A9AEAQ26773017-F33C4D88-B770-46C8-935D-05AFB3585C8FQ26773613-1E4D99A6-4934-4CBA-95D1-A9DE90D0483CQ26785501-2694E376-662C-4C2E-9692-A2BEE2496145Q27025688-2F532B0C-E075-41B7-ADE4-CC6D3FE4F158Q28141482-AA2C5FB7-D554-4E4C-9D9A-D1B7DCFE3DC4Q28191731-00796F01-7CBD-4402-A939-6196A54955D7Q28251189-DFE04656-33C1-47EE-A666-7F08984B8EDCQ28261795-5A796D73-A8C6-483E-82BC-26D0ADC9D58CQ28287394-D235F48D-A2FC-452C-9171-9AE145225F2DQ28290224-8027A559-D5CB-49B6-881A-F6C5D0A169DBQ28308042-A7149D0C-4DF3-4CA4-B008-A40C544BFF27Q28384638-D406CD6D-EDC0-438E-91FE-18588846A37CQ28385366-905609D7-A297-44FB-9B69-D191CE328D82Q28513445-37A62922-250C-4324-B621-4DEA9214E209Q28538066-CFF3F3CF-9923-4E82-AB2B-DF6CBB6DB884Q28538824-254BC752-38AB-4480-ADC2-9601FC0EB602Q28731449-7FAB5F30-19AA-44EC-9EB1-135E29114AE4Q28749299-30E98A4A-EC62-45C0-AAB5-58FF7106C59DQ29547556-943F0E6F-4321-428A-8635-E3864CE496CCQ30419245-A9F7438E-D908-439D-9C2B-0CF0B6223780
P2860
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@ast
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@en
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@nl
type
label
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@ast
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@en
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@nl
prefLabel
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@ast
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@en
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@nl
P2093
P2860
P921
P3181
P356
P1476
Tumor necrosis factor receptor ...... uced by osteoprotegerin ligand
@en
P2093
A Colombero
C Capparelli
C R Dunstan
G Shimamoto
P2860
P304
P3181
P356
10.1073/PNAS.96.7.3540
P407
P577
1999-03-30T00:00:00Z